Is KMC Speciality overvalued or undervalued?

As of 8 October 2025, KMC Speciality's valuation grade has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued based on its financial metrics, with a PE ratio of 52.54, an EV to EBITDA of 21.73, and a ROCE of 15.52%. In comparison to its peers, Apollo Hospitals, which is rated attractive, has a significantly higher PE ratio of 70.05, while Narayana Hrudaya, rated expensive, has a PE of 46.14.
Despite the fair valuation, KMC Speciality's stock has recently outperformed the Sensex, with a 1-week return of 14.14% compared to the Sensex's 0.98%. However, the company's year-to-date return of -1.68% suggests some challenges ahead. Overall, KMC Speciality appears to be fairly valued in the current market landscape.